Animal Genetics Market by Animal (Bovine, Porcine), Products & Services (Genetic Materials, Genetic Testing Services), Technology (PCR, NGS, rDNA, Microarray Technology), End User (Animal Farms, Veterinary Hospitals & Clinics) - Global Forecast to 2029
The global animal genetics market is projected to reach USD 4.19 billion by 2029 from USD 2.97 billion in 2024, at a CAGR of 7.1% during the forecast period. The rising consumption of animal-based products, coupled with the adoption of advanced genetic testing techniques, growing animal welfare initiatives, and the increasing demand for companion animals, is driving the growth of the animal genetics market. This growth reflects a global shift towards improved livestock productivity, better breeding practices, and enhanced animal care. To address the expanding demand for high-quality animal-derived food products, companies are focusing on developing superior sires with desirable quantitative traits. By leveraging advance genetic technologies, businesses aim to create livestock that meets industry demands while reducing production costs and environmental impact. These advancements not only contribute to meeting food security goals but also align with sustainability and animal welfare standards, ensuring a balance between productivity and ethical practices.
“Porcine segment accounted for the second largest market share of the animal genetics market in 2023.”
The porcine segment held the second-largest market share in the animal genetics market in 2023, driven by the increasing global demand for pork and pork-based products. Rising awareness of the benefits of genetically improved pigs, such as enhanced disease resistance, higher reproductive efficiency, and improved feed conversion rates, has further fueled growth in this segment. Additionally, increased pork production and consumption in major markets, such as China, the United States, and the European Union, has significantly boosted demand for superior porcine breeds. This trend is further supported by the rising popularity of high-quality pork products in emerging economies.
“Genetic testing services is projected to grow at the fastest rate of 8.9% in the animal genetics market during the forecast period.”
Genetic testing services are expected to grow at the fastest rate of 8.9% in the animal genetics market during the forecast period. This growth is driven by the increasing emphasis on preventing genetic diseases in animals through advanced testing services, enabling early detection and targeted breeding strategies. Innovations in phenotyping services, which allow detailed analysis of observable traits, are also propelling the demand for genetic testing. These advancements help optimize breeding programs by identifying animals with desirable traits more accurately. Additionally, the rising need for genetic validation in high-value livestock and companion animals further contributes to the rapid expansion of this segment.
“The NGS Technology segment is expected to witness the second highest growth rate of 10.9% in the animal genetics market during the forest period.”
The NGS (Next-Generation Sequencing) technology segment is projected to grow at the second highest CAGR of 10.9% in the animal genetics market during the forecast period. This rapid growth is driven by the ability of NGS to analyze entire genomes with high speed and accuracy, making it invaluable for identifying genetic markers and variations. Its applications in genome-wide association studies, parentage verification, and disease susceptibility analysis are fueling its demand. Additionally, the decreasing costs of sequencing and the growing focus on precision breeding to enhance productivity and disease resistance in livestock are further propelling the adoption of NGS in animal genetics.
“In 2023, the Diagnostic Center segment has accounted for the second largest share in the animal genetics market.”
In 2023, the Diagnostic Center segment held the second-largest share in the animal genetics market. This is driven by the increasing prevalence of genetic disorders in animals and the growing need for early and accurate diagnosis. Diagnostic centers play a crucial role in offering specialized genetic testing services, enabling better disease management and informed breeding decisions. The rise in pet ownership and livestock health awareness has further boosted the demand for these services. Moreover, advancements in diagnostic tools, such as PCR and microarray technology, have improved the efficiency and accessibility of genetic testing, contributing to the growth of this segment.
“North America region counted for the second largest share in the animal genetics market in 2023.”
In 2023, North America accounted for the second-largest share in the animal genetics market, driven by the region's well-established livestock and pet industries. High investments in animal healthcare and advanced breeding programs have significantly contributed to market growth. Additionally, the presence of leading genetic research institutes and companies, along with strong government support for agricultural and veterinary advancements, has bolstered this segment. The increasing adoption of precision farming techniques and the rising demand for high-quality animal products, such as premium meat and dairy, further strengthen North America’s position in the animal genetics market.
The break-up of the profile of primary participants in the animal genetics market: Supply-side
Research Coverage:
The report analyzes the animal genetics market and aims at estimating the market size and future growth potential of this market based on segments such as animal type, product & service, technology, end user and region. The report also includes a product portfolio matrix of various animal genetics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall animal genetics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
“Porcine segment accounted for the second largest market share of the animal genetics market in 2023.”
The porcine segment held the second-largest market share in the animal genetics market in 2023, driven by the increasing global demand for pork and pork-based products. Rising awareness of the benefits of genetically improved pigs, such as enhanced disease resistance, higher reproductive efficiency, and improved feed conversion rates, has further fueled growth in this segment. Additionally, increased pork production and consumption in major markets, such as China, the United States, and the European Union, has significantly boosted demand for superior porcine breeds. This trend is further supported by the rising popularity of high-quality pork products in emerging economies.
“Genetic testing services is projected to grow at the fastest rate of 8.9% in the animal genetics market during the forecast period.”
Genetic testing services are expected to grow at the fastest rate of 8.9% in the animal genetics market during the forecast period. This growth is driven by the increasing emphasis on preventing genetic diseases in animals through advanced testing services, enabling early detection and targeted breeding strategies. Innovations in phenotyping services, which allow detailed analysis of observable traits, are also propelling the demand for genetic testing. These advancements help optimize breeding programs by identifying animals with desirable traits more accurately. Additionally, the rising need for genetic validation in high-value livestock and companion animals further contributes to the rapid expansion of this segment.
“The NGS Technology segment is expected to witness the second highest growth rate of 10.9% in the animal genetics market during the forest period.”
The NGS (Next-Generation Sequencing) technology segment is projected to grow at the second highest CAGR of 10.9% in the animal genetics market during the forecast period. This rapid growth is driven by the ability of NGS to analyze entire genomes with high speed and accuracy, making it invaluable for identifying genetic markers and variations. Its applications in genome-wide association studies, parentage verification, and disease susceptibility analysis are fueling its demand. Additionally, the decreasing costs of sequencing and the growing focus on precision breeding to enhance productivity and disease resistance in livestock are further propelling the adoption of NGS in animal genetics.
“In 2023, the Diagnostic Center segment has accounted for the second largest share in the animal genetics market.”
In 2023, the Diagnostic Center segment held the second-largest share in the animal genetics market. This is driven by the increasing prevalence of genetic disorders in animals and the growing need for early and accurate diagnosis. Diagnostic centers play a crucial role in offering specialized genetic testing services, enabling better disease management and informed breeding decisions. The rise in pet ownership and livestock health awareness has further boosted the demand for these services. Moreover, advancements in diagnostic tools, such as PCR and microarray technology, have improved the efficiency and accessibility of genetic testing, contributing to the growth of this segment.
“North America region counted for the second largest share in the animal genetics market in 2023.”
In 2023, North America accounted for the second-largest share in the animal genetics market, driven by the region's well-established livestock and pet industries. High investments in animal healthcare and advanced breeding programs have significantly contributed to market growth. Additionally, the presence of leading genetic research institutes and companies, along with strong government support for agricultural and veterinary advancements, has bolstered this segment. The increasing adoption of precision farming techniques and the rising demand for high-quality animal products, such as premium meat and dairy, further strengthen North America’s position in the animal genetics market.
The break-up of the profile of primary participants in the animal genetics market: Supply-side
- By Company Type: Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25%
- By Designation: C Level – 25%, Director Level – 55%, Others-20%
- By Region: North America – 40%, Europe – 25%, Asia Pacific – 20%, Latin America – 10%, and Middle East & Africa– 5%
- By End User: Animal Farms – 45%, Veterinary Hospitals & Clinics – 30%, Diagnostic Centers – 15% and Research Institutes – 10%
- By Designation: Veterinarians – 45%, Farm Owners – 40%, and Labpratory Technicians – 15%
- By Region: North America – 34%, Europe – 27%, Asia Pacific – 23%, Latin America – 9%, and Middle East & Africa– 7%
Research Coverage:
The report analyzes the animal genetics market and aims at estimating the market size and future growth potential of this market based on segments such as animal type, product & service, technology, end user and region. The report also includes a product portfolio matrix of various animal genetics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall animal genetics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
- Analysis of key drivers (increasing consumption of animal-derived protein and dairy products, growing global population and rapid urbanization, growing awareness regarding animal health and benefits of animal genetic tests & products, prevention of genetic diseases through advanced genetic services, increased adoption of advanced genetic technologies), restraints (High costs of genetic testing and technologies), opportunities (untapped market potential in developing countries, innovations in phenotyping services, increasing investments in organic growth and R&D), and challenges (Need for specific breeding programs for breeds with inferior economic performance, Complex regulatory and ethical landscape, Shortage of skilled professionals in veterinary research) influencing the growth of the animal genetics market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the animal genetics market
- Market Development: Comprehensive information on the lucrative emerging markets by type, usage, end user and region.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global animal genetics market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Neogen Corporation (US), Genus PLC (UK), Urus (US), and Groupe Grimaud (France) in the global animal genetics market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKETS COVERED
1.3.1 MARKETS & REGIONS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY SOURCES
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ANIMAL GENETICS MARKET OVERVIEW
4.2 ASIA PACIFIC ANIMAL GENETICS MARKET, BY TECHNOLOGY AND COUNTRY
4.3 ANIMAL GENETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 ANIMAL GENETICS MARKET: REGIONAL MIX
4.5 ANIMAL GENETICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing consumption of animal-derived protein and dairy products
5.2.1.2 Growing global population and rapid urbanization
5.2.1.3 Growing awareness regarding animal health and benefits of animal genetic tests & products
5.2.1.4 Prevention of genetic diseases through advanced genetic services
5.2.1.5 Increased adoption of advanced genetic technologies
5.2.2 RESTRAINTS
5.2.2.1 High costs of genetic testing and technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped market potential in developing countries
5.2.3.2 Innovations in phenotyping services
5.2.3.3 Increasing investments in organic growth strategies and R&D
5.2.4 CHALLENGES
5.2.4.1 Need for specific breeding programs for breeds with inferior economic performance
5.2.4.2 Complex regulatory and ethical landscape
5.2.4.3 Shortage of skilled professionals in veterinary research
5.3 INDUSTRY TRENDS
5.3.1 RISING RESEARCH COLLABORATION AND PARTNERSHIPS
5.3.2 CHANGING DYNAMICS IN CHINESE PORCINE MARKET
5.3.3 USE OF ARTIFICIAL INTELLIGENCE IN ANIMAL BREEDING AND TESTING
5.3.4 INTRODUCTION OF GENETICALLY MODIFIED DISEASE-RESISTANT ANIMALS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 CRISPR-Cas9 Gene editing
5.4.1.2 Precision phenotyping
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Artificial insemination
5.4.2.2 Embryo transfer technology
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Artificial Intelligence (AI)
5.4.3.2 Precision livestock farming
5.5 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.6.2 BUYING CRITERIA
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.2 REGULATORY FRAMEWORK
5.7.2.1 US
5.7.2.2 Europe
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR ANIMAL GENETICS MARKET
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 IMPORT SCENARIO (HS CODE 051110)
5.9.2 EXPORT SCENARIO (HS CODE 051110)
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE, BY KEY PLAYER
5.10.2 AVERAGE SELLING PRICE, BY REGION
5.11 REIMBURSEMENT ANALYSIS
5.12 KEY CONFERENCES AND EVENTS, 2024?2025
5.13 UNMET NEEDS/END-USER EXPECTATIONS IN ANIMAL GENETICS MARKET
5.14 VALUE CHAIN ANALYSIS
5.15 SUPPLY CHAIN ANALYSIS
5.16 ECOSYSTEM ANALYSIS
5.17 CASE STUDY ANALYSIS
5.17.1 PRECISION BREEDING FOR DISEASE RESISTANCE
5.17.2 IMPROVING DAIRY PRODUCTION WITH GENOMICS
5.17.3 ZOETIS PARTNERS WITH VAS
5.18 ADJACENT MARKETS
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESSES
5.20 ANIMAL GENETICS MARKET: INVESTMENT & FUNDING SCENARIO
5.21 IMPACT OF AI/GEN AI ON ANIMAL GENETICS MARKET
5.21.1 KEY USE CASES
6 ANIMAL GENETICS MARKET, BY ANIMAL TYPE
6.1 INTRODUCTION
6.2 BOVINE
6.2.1 BOVINE GENETICS TO HOLD LARGEST MARKET SHARE
6.3 PORCINE
6.3.1 INCREASING APPLICATIONS OF ADVANCED GENETIC TECHNIQUES TO AID MARKET GROWTH
6.4 CANINE
6.4.1 RISING AWARENESS OF GENETIC HEALTH IN DOGS TO SUPPORT GROWTH
6.5 POULTRY
6.5.1 RISING DEMAND FOR CHICKEN AND EGG AS PRIMARY PROTEIN SOURCES TO DRIVE MARKET
6.6 OTHER ANIMALS
7 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
7.2 ANIMAL GENETIC MATERIALS
7.2.1 SEMEN
7.2.1.1 Bovine semen
7.2.1.1.1 Bovine semen to register highest growth rate during study period
7.2.1.2 Porcine semen
7.2.1.2.1 Rising use of artificial insemination to propel market growth
7.2.1.3 Equine semen
7.2.1.3.1 Stringent regulations for disease control to pose challenges for equine industry breeders
7.2.1.4 Canine semen
7.2.1.4.1 Increasing adoption of dogs as companion animals to drive market
7.2.1.4.2 Other animal semen
7.2.2 EMBRYOS
7.2.2.1 Bovine embryos
7.2.2.1.1 Growing popularity among seed stock and beef producers to support market growth
7.2.2.2 Equine embryos
7.2.2.2.1 Argentina, Brazil, and US to hold leading shares in embryo transfer technology
7.2.2.2.2 Other animal embryos
7.3 ANIMAL GENETIC TESTING SERVICES
7.3.1 GENETIC DISEASE TESTS
7.3.1.1 Genetic disease tests to witness highest growth in testing services market
7.3.2 GENETIC TRAIT TESTS
7.3.2.1 Bovine genetic trait tests
7.3.2.1.1 Focus on high-productivity traits in herds to drive demand
7.3.2.2 Other genetic trait tests
7.3.3 DNA TYPING
7.3.3.1 Emphasis on parentage identification, animal registration, and gender-associated disease identification to propel market
7.3.4 OTHER SERVICES
8 ANIMAL GENETICS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 NGS
8.2.1 NGS TO HOLD LARGEST MARKET SHARE
8.3 PCR
8.3.1 COST-EFFECTIVENESS, SIMPLICITY, AND HIGH ACCURACY TO DRIVE MARKET
8.4 RDNA
8.4.1 ABILITY TO SUPPORT GENETIC ENGINEERING AND GMOS TO SUPPORT MARKET GROWTH
8.5 MICROARRAYS
8.5.1 RAPID ANALYTICAL CAPABILITIES TO PROPEL ADOPTION OF MICROARRAYS
8.6 OTHER TECHNOLOGIES
9 ANIMAL GENETICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 ANIMAL FARMS
9.2.1 GROWING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
9.3 VETERINARY HOSPITALS & CLINICS
9.3.1 RISING INVESTMENTS AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL GROWTH
9.4 DIAGNOSTIC CENTERS
9.4.1 RISING DEMAND FOR ACCURATE AND TIMELY DIAGNOSIS TO SUPPORT MARKET GROWTH
9.5 RESEARCH INSTITUTES
9.5.1 INCREASED FUNDING FOR RESEARCH AND GOVERNMENT INITIATIVES TO DRIVE MARKET
10 ANIMAL GENETICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Adoption of advanced genetic testing methods to drive market growth
10.2.3 CANADA
10.2.3.1 Growing demand for genetic material to boost market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Growing demand for poultry genetics drives the animal genetics market
10.3.3 UK
10.3.3.1 Selective breeding programs and efforts to improve breed productivity to drive demand for animal genetics
10.3.4 FRANCE
10.3.4.1 Growing domestic demand for livestock and poultry products to propel market growth
10.3.5 ITALY
10.3.5.1 Government focus on preserving local breeds to support market growth
10.3.6 SPAIN
10.3.6.1 Rising domestic consumption of pork and poultry products to drive market
10.3.7 NETHERLANDS
10.3.7.1 Strong livestock sector and growing presence of major players to drive market
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA
10.4.2 CHINA
10.4.2.1 China to hold largest share of APAC market
10.4.3 INDIA
10.4.3.1 Large-scale production of live bovines to drive market
10.4.4 JAPAN
10.4.4.1 Increased production and consumption of livestock products to drive market growth
10.4.5 AUSTRALIA
10.4.5.1 Increased demand for animal-based food products to propel market growth
10.4.6 SOUTH KOREA
10.4.6.1 Increased consumption of high-quality animal products to augment market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK OF LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Brazil to hold largest share of LATAM market
10.5.3 MEXICO
10.5.3.1 High demand for animal meat to drive market growth in Mexico
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK OF MIDDLE EAST AND AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Emphasis on improving animal welfare standards to support market demand
10.6.3 REST OF MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021–OCTOBER 2024
11.3 REVENUE ANALYSIS, 2019?2023
11.4 MARKET SHARE ANALYSIS, 2023
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Animal type footprint
11.5.5.4 Product & service footprint
11.5.5.5 Technology footprint
11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
11.7 R&D EXPENDITURE OF KEY PLAYERS
11.8 COMPANY VALUATION & FINANCIAL METRICS
11.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT/SERVICE APPROVALS & LAUNCHES
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 NEOGEN CORPORATION
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product/Service launches
12.1.1.3.2 Deals
12.1.1.3.3 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 GENUS PLC
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 GENETIC TECHNOLOGIES LIMITED
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.3.2 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 URUS
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Services launches
12.1.4.3.2 Deals
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 SELECT SIRES INC.
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 GROUPE GRIMAUD
12.1.6.1 Business overview
12.1.6.2 Products & services offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 CRV HOLDING
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 TOPIGS NORSVIN
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.8.3 Recent developments
12.1.8.3.1 Expansions
12.1.9 ZOETIS, INC.
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.9.3 Recent developments
12.1.9.3.1 Services launches
12.1.9.3.2 Deals
12.1.10 VETGENOMICS SL
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.11 QUANTUM GENETIX
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.12 ANIMAL GENETICS, INC.
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.2 OTHER PLAYERS
12.2.1 LABOKLIN GMBH & CO. KG
12.2.2 DANBRED P/S
12.2.3 TROPICAL ANIMAL GENETICS
12.2.4 INGURAN LLC DBA STGENETICS
12.2.5 SEMEX
12.2.6 SUPERIOR ANIMAL GENETICS
12.2.7 XYTOVET
12.2.8 SWINE GENETICS INTERNATIONAL
12.2.9 GENERATIO GMBH
12.2.10 COGENT BREEDING LTD
12.2.11 WEATHERBYS SCIENTIFIC
12.2.12 GENSOL DIAGNOSTICS, LLC.
12.2.13 SANDOR ANIMAL BIOGENICS PVT. LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKETS COVERED
1.3.1 MARKETS & REGIONS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY SOURCES
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ANIMAL GENETICS MARKET OVERVIEW
4.2 ASIA PACIFIC ANIMAL GENETICS MARKET, BY TECHNOLOGY AND COUNTRY
4.3 ANIMAL GENETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 ANIMAL GENETICS MARKET: REGIONAL MIX
4.5 ANIMAL GENETICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing consumption of animal-derived protein and dairy products
5.2.1.2 Growing global population and rapid urbanization
5.2.1.3 Growing awareness regarding animal health and benefits of animal genetic tests & products
5.2.1.4 Prevention of genetic diseases through advanced genetic services
5.2.1.5 Increased adoption of advanced genetic technologies
5.2.2 RESTRAINTS
5.2.2.1 High costs of genetic testing and technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped market potential in developing countries
5.2.3.2 Innovations in phenotyping services
5.2.3.3 Increasing investments in organic growth strategies and R&D
5.2.4 CHALLENGES
5.2.4.1 Need for specific breeding programs for breeds with inferior economic performance
5.2.4.2 Complex regulatory and ethical landscape
5.2.4.3 Shortage of skilled professionals in veterinary research
5.3 INDUSTRY TRENDS
5.3.1 RISING RESEARCH COLLABORATION AND PARTNERSHIPS
5.3.2 CHANGING DYNAMICS IN CHINESE PORCINE MARKET
5.3.3 USE OF ARTIFICIAL INTELLIGENCE IN ANIMAL BREEDING AND TESTING
5.3.4 INTRODUCTION OF GENETICALLY MODIFIED DISEASE-RESISTANT ANIMALS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 CRISPR-Cas9 Gene editing
5.4.1.2 Precision phenotyping
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Artificial insemination
5.4.2.2 Embryo transfer technology
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Artificial Intelligence (AI)
5.4.3.2 Precision livestock farming
5.5 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.6.2 BUYING CRITERIA
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.2 REGULATORY FRAMEWORK
5.7.2.1 US
5.7.2.2 Europe
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR ANIMAL GENETICS MARKET
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 IMPORT SCENARIO (HS CODE 051110)
5.9.2 EXPORT SCENARIO (HS CODE 051110)
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE, BY KEY PLAYER
5.10.2 AVERAGE SELLING PRICE, BY REGION
5.11 REIMBURSEMENT ANALYSIS
5.12 KEY CONFERENCES AND EVENTS, 2024?2025
5.13 UNMET NEEDS/END-USER EXPECTATIONS IN ANIMAL GENETICS MARKET
5.14 VALUE CHAIN ANALYSIS
5.15 SUPPLY CHAIN ANALYSIS
5.16 ECOSYSTEM ANALYSIS
5.17 CASE STUDY ANALYSIS
5.17.1 PRECISION BREEDING FOR DISEASE RESISTANCE
5.17.2 IMPROVING DAIRY PRODUCTION WITH GENOMICS
5.17.3 ZOETIS PARTNERS WITH VAS
5.18 ADJACENT MARKETS
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESSES
5.20 ANIMAL GENETICS MARKET: INVESTMENT & FUNDING SCENARIO
5.21 IMPACT OF AI/GEN AI ON ANIMAL GENETICS MARKET
5.21.1 KEY USE CASES
6 ANIMAL GENETICS MARKET, BY ANIMAL TYPE
6.1 INTRODUCTION
6.2 BOVINE
6.2.1 BOVINE GENETICS TO HOLD LARGEST MARKET SHARE
6.3 PORCINE
6.3.1 INCREASING APPLICATIONS OF ADVANCED GENETIC TECHNIQUES TO AID MARKET GROWTH
6.4 CANINE
6.4.1 RISING AWARENESS OF GENETIC HEALTH IN DOGS TO SUPPORT GROWTH
6.5 POULTRY
6.5.1 RISING DEMAND FOR CHICKEN AND EGG AS PRIMARY PROTEIN SOURCES TO DRIVE MARKET
6.6 OTHER ANIMALS
7 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
7.2 ANIMAL GENETIC MATERIALS
7.2.1 SEMEN
7.2.1.1 Bovine semen
7.2.1.1.1 Bovine semen to register highest growth rate during study period
7.2.1.2 Porcine semen
7.2.1.2.1 Rising use of artificial insemination to propel market growth
7.2.1.3 Equine semen
7.2.1.3.1 Stringent regulations for disease control to pose challenges for equine industry breeders
7.2.1.4 Canine semen
7.2.1.4.1 Increasing adoption of dogs as companion animals to drive market
7.2.1.4.2 Other animal semen
7.2.2 EMBRYOS
7.2.2.1 Bovine embryos
7.2.2.1.1 Growing popularity among seed stock and beef producers to support market growth
7.2.2.2 Equine embryos
7.2.2.2.1 Argentina, Brazil, and US to hold leading shares in embryo transfer technology
7.2.2.2.2 Other animal embryos
7.3 ANIMAL GENETIC TESTING SERVICES
7.3.1 GENETIC DISEASE TESTS
7.3.1.1 Genetic disease tests to witness highest growth in testing services market
7.3.2 GENETIC TRAIT TESTS
7.3.2.1 Bovine genetic trait tests
7.3.2.1.1 Focus on high-productivity traits in herds to drive demand
7.3.2.2 Other genetic trait tests
7.3.3 DNA TYPING
7.3.3.1 Emphasis on parentage identification, animal registration, and gender-associated disease identification to propel market
7.3.4 OTHER SERVICES
8 ANIMAL GENETICS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 NGS
8.2.1 NGS TO HOLD LARGEST MARKET SHARE
8.3 PCR
8.3.1 COST-EFFECTIVENESS, SIMPLICITY, AND HIGH ACCURACY TO DRIVE MARKET
8.4 RDNA
8.4.1 ABILITY TO SUPPORT GENETIC ENGINEERING AND GMOS TO SUPPORT MARKET GROWTH
8.5 MICROARRAYS
8.5.1 RAPID ANALYTICAL CAPABILITIES TO PROPEL ADOPTION OF MICROARRAYS
8.6 OTHER TECHNOLOGIES
9 ANIMAL GENETICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 ANIMAL FARMS
9.2.1 GROWING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
9.3 VETERINARY HOSPITALS & CLINICS
9.3.1 RISING INVESTMENTS AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL GROWTH
9.4 DIAGNOSTIC CENTERS
9.4.1 RISING DEMAND FOR ACCURATE AND TIMELY DIAGNOSIS TO SUPPORT MARKET GROWTH
9.5 RESEARCH INSTITUTES
9.5.1 INCREASED FUNDING FOR RESEARCH AND GOVERNMENT INITIATIVES TO DRIVE MARKET
10 ANIMAL GENETICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Adoption of advanced genetic testing methods to drive market growth
10.2.3 CANADA
10.2.3.1 Growing demand for genetic material to boost market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Growing demand for poultry genetics drives the animal genetics market
10.3.3 UK
10.3.3.1 Selective breeding programs and efforts to improve breed productivity to drive demand for animal genetics
10.3.4 FRANCE
10.3.4.1 Growing domestic demand for livestock and poultry products to propel market growth
10.3.5 ITALY
10.3.5.1 Government focus on preserving local breeds to support market growth
10.3.6 SPAIN
10.3.6.1 Rising domestic consumption of pork and poultry products to drive market
10.3.7 NETHERLANDS
10.3.7.1 Strong livestock sector and growing presence of major players to drive market
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA
10.4.2 CHINA
10.4.2.1 China to hold largest share of APAC market
10.4.3 INDIA
10.4.3.1 Large-scale production of live bovines to drive market
10.4.4 JAPAN
10.4.4.1 Increased production and consumption of livestock products to drive market growth
10.4.5 AUSTRALIA
10.4.5.1 Increased demand for animal-based food products to propel market growth
10.4.6 SOUTH KOREA
10.4.6.1 Increased consumption of high-quality animal products to augment market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK OF LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Brazil to hold largest share of LATAM market
10.5.3 MEXICO
10.5.3.1 High demand for animal meat to drive market growth in Mexico
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK OF MIDDLE EAST AND AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Emphasis on improving animal welfare standards to support market demand
10.6.3 REST OF MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021–OCTOBER 2024
11.3 REVENUE ANALYSIS, 2019?2023
11.4 MARKET SHARE ANALYSIS, 2023
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Animal type footprint
11.5.5.4 Product & service footprint
11.5.5.5 Technology footprint
11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
11.7 R&D EXPENDITURE OF KEY PLAYERS
11.8 COMPANY VALUATION & FINANCIAL METRICS
11.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT/SERVICE APPROVALS & LAUNCHES
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 NEOGEN CORPORATION
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product/Service launches
12.1.1.3.2 Deals
12.1.1.3.3 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 GENUS PLC
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 GENETIC TECHNOLOGIES LIMITED
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.3.2 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 URUS
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Services launches
12.1.4.3.2 Deals
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 SELECT SIRES INC.
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 GROUPE GRIMAUD
12.1.6.1 Business overview
12.1.6.2 Products & services offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 CRV HOLDING
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 TOPIGS NORSVIN
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.8.3 Recent developments
12.1.8.3.1 Expansions
12.1.9 ZOETIS, INC.
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.9.3 Recent developments
12.1.9.3.1 Services launches
12.1.9.3.2 Deals
12.1.10 VETGENOMICS SL
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.11 QUANTUM GENETIX
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.12 ANIMAL GENETICS, INC.
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.2 OTHER PLAYERS
12.2.1 LABOKLIN GMBH & CO. KG
12.2.2 DANBRED P/S
12.2.3 TROPICAL ANIMAL GENETICS
12.2.4 INGURAN LLC DBA STGENETICS
12.2.5 SEMEX
12.2.6 SUPERIOR ANIMAL GENETICS
12.2.7 XYTOVET
12.2.8 SWINE GENETICS INTERNATIONAL
12.2.9 GENERATIO GMBH
12.2.10 COGENT BREEDING LTD
12.2.11 WEATHERBYS SCIENTIFIC
12.2.12 GENSOL DIAGNOSTICS, LLC.
12.2.13 SANDOR ANIMAL BIOGENICS PVT. LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
